Search Results
Mar 03, 2026, 22:47 ET Tierra Mojada Luxembourg II S.à r.l. announces commencement of a consent solicitation for its 5.750% Senior Secured Notes due 2040
the Solicitation Agents and the Information & Tabulation Agent; (ii) to extend such Consent Solicitation for any reason from time to time; and (iii) not to extend such Consent Solicitation beyond the original Expiration Time or any date to which such Consent Solicitation has been previously extended.Mizuho
More news about: Tierra Mojada Luxembourg II S.à r.l.
Mar 03, 2026, 20:22 ET VERSABANK REPORTS STRONG FIRST QUARTER RESULTS: ACCELERATED U.S. GROWTH DRIVES 31% YEAR-OVER-YEAR INCREASE IN REVENUE, 36% YEAR-OVER-YEAR GROWTH IN NET INCOME, 49% YEAR-OVER-YEAR GROWTH IN ADJUSTED NET INCOME
** Capital management and leverage measures are in accordance with OSFI's Capital Adequacy Requirements and Basel III Accord.SEGMENTED FINANCIAL SUMMARY – QUARTERLY
More news about: VersaBank
Mar 03, 2026, 17:31 ET Chronic Kidney Disease Market Poised to Expand Significantly During Forecast Period (2025-2034) as Demand for Early Diagnosis and Novel Therapies Increases | DelveInsight
aldosterone synthase inhibitor, is designed to slow the progression of renal damage and reduce cardiovascular risk in CKD. It is currently in the Phase III EASi-KIDNEY trial, where it is being studied alongside empagliflozin, another SGLT2 inhibitor, to provide additional kidney protection. Boehringer Ingelheim
More news about: DelveInsight Business Research, LLP
Mar 03, 2026, 17:29 ET Bitmine Immersion Technologies (BMNR) annuncia che le partecipazioni in ETH raggiungono i 4,474 milioni di token, mentre le partecipazioni totali in criptovalute e contanti ammontano a 9,9 miliardi di dollari
continua a essere sostenuta da un gruppo di investitori istituzionali di prim'ordine tra cui Cathie Wood di ARK, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital e l'investitore privato Thomas "Tom" Lee a sostegno dell'obiettivo di Bitmine di acquisire il 5% di ETH
More news about: Bitmine Immersion Technologies, Inc.
Mar 03, 2026, 17:27 ET Bitmine Immersion Technologies (BMNR) 宣佈其以太幣持有量達 447.4 萬枚代幣，加密資產及現金總持有額達 99 億美元
Bitmine 為美國成交量排名第 145 位的股票，5 日平均每日成交額達 8 億美元Bitmine 持續獲得頂級機構投資者支持，包括 ARK 的 Cathie Wood、MOZAYYX、Founders Fund、Bill Miller III、Pantera、Kraken、DCG、Galaxy Digital 以及個人投資者 Thomas "Tom" Lee，攜手支持 Bitmine 收購 5% 以太幣的目標拉斯維加斯2026年3月4日
More news about: Bitmine Immersion Technologies, Inc.
Mar 03, 2026, 17:25 ET Bitmine Immersion Technologies (BMNR) anuncia que suas participações em ETH atingiram 4,474 milhões de tokens, e que suas participações totais em criptomoedas e em caixa somam US$ 9,9 bilhões
a contar com o apoio de um grupo de investidores institucionais de primeira linha, incluindo Cathie Wood da ARK, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital e o investidor pessoal Thomas "Tom" Lee, para apoiar o objetivo da Bitmine de adquirir 5% do ETH
More news about: Bitmine Immersion Technologies, Inc.
Mar 03, 2026, 17:20 ET Bitmine Immersion Technologies (BMNR) anuncia que sus tenencias de ETH alcanzan los 4.474 millones de tokens y que sus tenencias totales de criptomonedas y efectivo ascienden a 9.900 millones de dólares
respaldo de un grupo de inversionistas institucionales de primer nivel, entre los que se encuentran Cathie Wood de ARK, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital y el inversionista personal Thomas "Tom" Lee, con el fin de respaldar el objetivo de Bitmine de adquirir el 5 %
More news about: Bitmine Immersion Technologies, Inc.
Mar 03, 2026, 17:06 ET Perimeter Medical Imaging AI's 'Claire' Becomes First FDA-approved AI-Enabled Imaging Device for Breast Cancer Surgery
patient characteristics to help surgeons assess areas of interest during surgery. This use of AI is what makes Claire one of the few AI-enabled class III devices on the U.S. market today. A pre-determined change control plan (PCCP) was authorized as part of the PMA approval and includes planned AI enhancements
More news about: Perimeter Medical Imaging AI Inc.
Mar 03, 2026, 16:10 ET RARE Investors Have Opportunity to Lead Ultragenyx Pharmaceutical Inc. Securities Fraud Lawsuit
of the case: According to the lawsuit, defendants provided investors with material information concerning Ultragenyx's expected results for its Phase III Orbit and Cosmic Studies, which tested setrusumab (UX 143) in patients with Osteogenesis Imperfecta ("OI"). Defendants' statements included, among other
More news about: THE ROSEN LAW FIRM, P. A.
Mar 03, 2026, 16:04 ET QuickLogic Reports Fiscal Fourth Quarter and Full Year 2025 Financial Results
stock-based compensation, impairments, and restructuring costs, in calculating non-GAAP (i) income (loss) from operations, (ii) net income (loss), (iii) net income (loss) per share, and (iv) gross margin percentage. The Company provides this non-GAAP information to enable investors to evaluate its operating
More news about: QuickLogic Corporation
Mar 03, 2026, 16:01 ET Kewaunee Scientific and Nu Aire Inc. to Attend analytica 2026 in Munich
attendance at analytica 2026 represents an important opportunity to connect with global laboratory users, planners, and partners," said Thomas D. Hull III, President and CEO of Kewaunee Scientific Corporation. "Joining with NuAire and ibs tecnomara, we are excited to demonstrate the strength of our integrated
More news about: Kewaunee Scientific Corporation
Mar 03, 2026, 14:49 ET Bitmine Immersion Technologies (BMNR) Umumkan Kepemilikan ETH Mencapai 4,474 Juta Token dan Total Kepemilikan Kripto Maupun Total Uang Tunai Sebesar $9,9 Miliar
Bitmine tetap didukung oleh kelompok penting beranggotakan investor institusi seperti Cathie Wood dari ARK, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital, dan investor pribadi Thomas "Tom" Lee guna mendukung tujuan Bitmine untuk mengakuisisi 5% ETH
More news about: Bitmine Immersion Technologies, Inc.
Mar 03, 2026, 14:46 ET Bitmine Immersion Technologies (BMNR) maakt bekend dat het 4,474 miljoen ETH-tokens bezit en dat het totale crypto- en cashreserves USD 9,9 miljard bedraagt
blijft ondersteund worden door een vooraanstaande groep institutionele investeerders, waaronder Cathie Wood van ARK, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital en persoonlijke investeerder Thomas "Tom" Lee om het doel van Bitmine om 5% van ETH te verwerven te ondersteunen.
More news about: Bitmine Immersion Technologies, Inc.
Mar 03, 2026, 14:42 ET Bitmine Immersion Technologies (BMNR) annonce que ses avoirs en ETH atteignent 4,474 millions de jetons et que ses avoirs en cryptomonnaies et en liquidités s'élèvent à 9,9 milliards de dollars
Bitmine est toujours soutenu par un groupe d'investisseurs institutionnels de premier plan, dont Cathie Wood d'ARK, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital et l'investisseur privé Thomas « Tom » Lee, pour soutenir l'objectif de Bitmine visant à acquérir 5 % du nombre
More news about: Bitmine Immersion Technologies, Inc.
Mar 03, 2026, 12:04 ET Black Buffalo Announces 2025 Herd Preferred Award Winners
growth of markets in which we compete and in which our products are sold, (ii) unexpected increases in our expenses, including manufacturing expenses, (iii) delays or cancellations in spending by our suppliers or customers, (iv) delayed action on or issuance of marketing denial orders in response to our
More news about: Black Buffalo Inc.
Mar 03, 2026, 11:12 ET AIQ Solutions Announces a New Category III CPT Code for Determining Heterogeneity of Change Across All Lesions for Advanced Metastatic Cancer Used with TRAQinform IQ Technology
cancer. After years of rigorous clinical, regulatory, and operational work by AIQ, the American Medical Association (AMA) has approved a new Category III Current Procedural Terminology (CPT) code describing the unique output of AIQ's TRAQinform IQ technology. This milestone will help make advanced treatment
More news about: AIQ Solutions
Mar 03, 2026, 10:00 ET UDOT & SVN Auction Services announce major online auction
Louis B. Fisher, III, CAI, National Director of SVN Auction Services.Other properties up for auction include a 1.22 acre vacant parcel zoned Neighborhood Commercial, Residential and Agriculture in Syracuse. "This parcel has road frontage
More news about: SVN Auction Services, LLC
Mar 03, 2026, 10:00 ET Labaton Keller Sucharow LLP Announces Notice of Pendency and Proposed Settlement of Class Action, and Motion for Attorneys' Fees and Expenses in Vazquez v. Masimo Corporation
reasonable, and adequate; (ii) dismiss the Action with prejudice as provided in the Stipulation and Agreement of Settlement, dated August 14, 2025; (iii) for purposes of the Settlement only, finally certify the Settlement Class, finally certify Lead Plaintiffs as Class Representatives for the Settlement
More news about: Labaton Keller Sucharow LLP
Mar 03, 2026, 09:55 ET AT&T Business Collaborating with Geoforce to provide Industrial Asset Tracking
asset management has reached a point where scale, reliability, and enterprise alignment matter as much as the technology itself," said James MacLean III, CEO, Geoforce. "Organizations are no longer experimenting. They are standardizing. We believe this collaboration with AT&T Business reflects that
More news about: Geoforce, Inc.
Mar 03, 2026, 09:00 ET Shareholders that lost money on Ultragenyx Pharmaceutical Inc.(RARE) Urged to Join Class Action - Contact The Gross Law Firm to Learn More
decrease in annualized fracture rates or otherwise the Phase III Orbit and Cosmic studies were much less likely to be able to demonstrate such a link than management claimed. On December 29, 2025, Ultragenyx announced that both its Phase III Orbit and Cosmic Studies had not "achieved statistical significance
More news about: The Gross Law Firm
Mar 03, 2026, 09:00 ET Shareholders that lost money on Beyond Meat, Inc.(BYND) should contact The Gross Law Firm about pending Class Action - BYND
material, non-cash impairment charge; (ii) the foregoing was likely to impair Beyond Meat's ability to timely file its periodic filings with the SEC; and (iii) as a result, defendants' public statements were materially false and misleading at all relevant times.DEADLINE: March 24, 2026 Shareholders
More news about: The Gross Law Firm
Mar 03, 2026, 09:00 ET Class Action Filed Against Enphase Energy, Inc. (ENPH) Seeking Recovery for Investors - Contact The Gross Law Firm
its ability to manage its channel inventory; (ii) Enphase overstated its ability to mitigate effects arising from the termination of the 25D Credit; (iii) accordingly, Enphase overstated its financial and operational prospects; and (iv) as a result, the Company's public statements were materially false
More news about: The Gross Law Firm
Mar 03, 2026, 09:00 ET The Gross Law Firm Reminds CoreWeave, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 13, 2026 - CRWV
that CoreWeave's reliance on a single third-party data center supplier presented for CoreWeave's ability to meet customer demand for its services; (iii) the foregoing was reasonably likely to have a material negative impact on the Company's revenue; (iv) as a result, the Company's public statements were
More news about: The Gross Law Firm
Mar 03, 2026, 09:00 ET The Gross Law Firm Reminds Plug Power Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 3, 2026 - PLUG
facilities necessary to receive those funds; (ii) as such, Plug Power was likely to pivot toward more modest projects with less commercial upside; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.DEADLINE: April 3, 2026 Shareholders
More news about: The Gross Law Firm
Mar 03, 2026, 09:00 ET Inovio Pharmaceuticals, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before April 7, 2026 to Discuss Your Rights - INO
device was deficient; (ii) accordingly, Inovio was unlikely to submit it's lead product candidate, INO-3107 BLA to the FDA by the second half of 2024; (iii) Inovio had insufficient information to justify the INO-3107 BLA's eligibility for FDA accelerated approval or priority review; (iv) accordingly, INO-3107's
More news about: The Gross Law Firm